As an anticoagulant, Warfarin inhibits the vitamin K-dependent synthesis of biologically active forms of the clotting factors II, VII, IX, and X, as well as regulatory factors protein C, protein S, and protein Z. The suppression of these factors significantly reduces the blood’s clotting capability, thereby preventing the formation of harmful blood clots.